Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting primary and secondary mediation analyses of randomised trials and observational studies.
Full bibliographic reference
Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group, Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement. JAMA. 2021;326(11):1045-1056.
Language
English
PubMed ID
Relevant URLs (full-text if available)
Access the AGReMA checklist for reporting mediation analyses of randomised controlled trials and observational studies as a primary objective.
Access the AGReMA-SF checklist for reporting secondary mediation analyses within primary reports of randomised controlled trials and observational studies.
Reporting guideline website URL
Reporting guideline acronym
AGReMA
Study design
Clinical trials, Experimental studies, Observational studies
Applies to the whole report or to individual sections of the report?
Statistical methods and analyses
Additional information
Read about the development of the AGReMA reporting guideline.
Record last updated on
September 23, 2021
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.